11 Jul 2014 --- As a result of the successful conclusion of the regulatory process and customary closing conditions, Nestlé has completed its acquisition of Valeant Pharmaceuticals International’s commercialisation rights to several key injectable aesthetic dermatology products in the US and Canada, as announced on 28 May 2014. These rights will be integrated into Nestlé Skin Health and commercialised by Galderma.
